• Latest Posts
In Depth 26 Oct 2023

Behind closed doors: The unseen controversies and scandals in Alzheimer’s drug trials

Partnership to progress neurodegenerative disorder treatments

Minoryx can start phase 3 trial for cerebral adrenoleukodystrophy patients

Biogen ALS drug gets FDA ok

In Depth 21 Apr 2023

Gut microbiome: a promising target for Parkinson’s

€260M fund addresses dementia investment shortfall

ADVERTISEMENT
More News! 2 Mar 2023

Could new dementia treatment come from intestinal bacteria discovery?

Minoryx Therapeutics announces X-linked adrenoleukodystrophy data

Astex and Cardiff University Medicines Discovery Institute to collaborate on neurodegenerative diseases

Ubiquigent and University of Glasgow to collaborate on drug discovery

JPND launches €16.5M call for research on OMICS data for neurodegenerative diseases

ADVERTISEMENT